In advanced ovarian cancer, chemotherapy is sometimes given before surgery rather than after. Someone who was short of breath from fluid in the abdomen (ascites) and barely able to eat may, after one or two cycles, feel her appetite return and her steps grow lighter. That is a welcome sign. Yet this is often exactly the moment the medical team begins discussing an operation, and families naturally wonder: if she is doing so well, is surgery really necessary?
One distinction helps here. How a person feels and how much cancer remains inside the body are two different measures. Ascites, pain, poor appetite and fatigue are indirect signals produced by the tumour, and they often improve quickly when chemotherapy is working. Small deposits scattered across the surface of the peritoneum, by contrast, cause few symptoms and may not be visible on a CT scan. A falling tumour marker (CA-125) indicates response, not disappearance. Feeling better and having no disease left are not the same statement.
Chemotherapy given before an operation is called neoadjuvant chemotherapy, and in many treatment plans it is intended not to replace surgery but to make surgery safer and more complete. Once the tumour burden shrinks and the ascites settles, the operation that removes the remaining disease is called interval debulking surgery. Because ovarian cancer tends to spread across many surfaces inside the abdomen, drugs alone rarely clear every deposit, and studies have reported better outcomes when surgery leaves no visible tumour behind. These findings do not apply identically to every patient, which is why the decision is individual.
Whether and when surgery is appropriate depends on several things considered together: the degree of response to chemotherapy, the location and extent of remaining disease on imaging (particularly around the diaphragm, liver surface and mesentery), the trend in CA-125, the patient's overall condition and activity level, nutrition, muscle mass and anaemia, and the surgical team's assessment of whether complete removal of visible disease is achievable. When this is uncertain, a diagnostic laparoscopy is sometimes used to look inside and judge resectability.
Concern about the burden of open surgery is reasonable. That burden can, however, be prepared for. In the weeks beforehand, maintaining protein intake, walking a little every day, practising deep breathing, and correcting anaemia or nutritional deficits — an approach often called prehabilitation — is associated with smoother recovery. Depending on how far the disease has spread, bowel resection or a temporary stoma may be possible; asking the team to describe both the expected and the worst-case scenario in advance can reduce shock later.
Resting somewhere quiet, eating well and caring for one's state of mind between treatments can genuinely help. Difficulty arises when these things begin to substitute for the schedule of standard treatment. Chemotherapy cycles have defined intervals, and there is a window during which surgery is most feasible; missing it can narrow the options. There is also a practical safety question: during the period when white blood cell counts fall, a fever needs urgent assessment, so staying hours away from a hospital deserves thought. If herbal preparations, juices or high-dose supplements are being used, tell the treating team and pharmacist rather than keeping it private, so interactions and effects on the liver and kidneys can be checked.
Caregivers often feel they must hold everything steady alone. In practice this decision is shared with the patient and the medical team. Written questions make the conversation more concrete: where is the remaining disease on current imaging, and does complete removal look achievable? After how many cycles would surgery be timed? If surgery is declined, what is the alternative plan? Have genetic tests (BRCA, HRD) been done, and how will the results shape maintenance therapy afterwards? Attending together, and recording the explanation with permission, can help too.
This article provides general information and does not replace individual diagnosis or care. Please discuss any treatment decisions with your own medical team.